The CFTC Asks a Judge to Toss CME's Perpetual Futures Lawsuit

The Commodity Futures Trading Commission asked a federal judge this week to throw out CME Group's challenge to crypto perpetual futures, and the motion never defends the classification at the center of the case. The filing landed in the US District Court for the District of Columbia and argues one thing: CME has no standing to sue, because it has shown no injury. CME brought the case on 18 June over the agency's 29 May order, which cleared KalshiEX LLC's cash-settled bitcoin perpetual contract, BTCPERP, and told other designated contract markets they could list similar products as futures. The agency's answer is that CME is free to list them too. Whether a perpetual contract is a future or a swap is left open.

Why CME went to court

Perpetual futures have no expiry and no delivery date. Traders hold them open for as long as they like and pay each other a periodic funding rate, the mechanism that keeps the contract's price close to spot. CME's complaint is that those features answer to the Commodity Exchange Act's definition of a swap, and that the agency broke with earlier enforcement actions which treated crypto perpetuals that way. Swaps and futures carry different oversight and different customer eligibility, so the label decides who may trade. Crowdfund Insider adds that the exchange objected to the speed of the approval, which came within a day of Kalshi's submission and skipped public comment and rulemaking. That account, alone among six read here, renders CME's pleading as alleging "textbook competitive injury".

The agency answers on standing, not on the merits

The CFTC's language is dismissive. Its filing calls the case "much ado about nothing", a phrase every account carried.

"CME is wrong on the merits — perpetual futures are futures. But there is a more fundamental defect with this lawsuit: CME lacks standing," the agency wrote in the motion, in the passage American Banker quoted.

The Block's account of the same filing sharpens that point. The agency writes there that even if CME's assertions of competitive injury had substance, those injuries are self-inflicted and rest on the exchange's own refusal to list perpetual futures. Unchained quotes the agency saying nothing prevents CME from listing the same contracts Kalshi lists, and reading the Commodity Exchange Act as favoring "self-regulation, market integrity and fair competition among exchanges". The CFTC also pointed at CME's own numbers. Its bitcoin and ether-related futures ran higher in June and August than in May, the month the Kalshi order came out. Decrypt gives the same exhibit product by product, naming Bitcoin, Micro Bitcoin, Ethereum and Micro Ethereum futures.

Two dates for one filing

The accounts do not agree on when the motion was filed. The Block, Crowdfund Insider and American Banker date it 2 September. Decrypt and Unchained date it 3 September. CoinDesk says Wednesday and published a day later, which points to the earlier date without settling it. We could not establish which date the docket carries. What every account agrees on is the calendar ahead. CME's opposition is due 2 October, and the CFTC has asked for an oral hearing.

What the motion leaves for later

Standing is a threshold question, so a win for the agency would close the case without answering whether perpetuals are futures or swaps. That answer reaches past one docket. Kalshi has since filed to certify perpetual contracts on twelve altcoins, ether, XRP, Solana and Dogecoin among them, on Decrypt's account alone. CoinDesk, also alone, reports that Judge Colleen Kollar-Kotelly refused the agency's request to withhold the administrative record and told both sides to propose a combined briefing schedule. Kalshi's other products have been running through the courts on a separate track all summer, where judges have weighed state gambling law against federal jurisdiction, and the agency has separately tightened the self-certification route that lets new listings reach the market without prior review. Nothing in this motion touches those cases. What it does test is whether an incumbent exchange can challenge a rival's product line while the same door stands open to it.